MORGAN STANLEY - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 39 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$18,751
-44.1%
98,6860.0%0.00%
Q1 2023$33,553
+6.3%
98,686
+1.1%
0.00%
Q4 2022$31,560
-21.1%
97,618
+1.1%
0.00%
Q3 2022$40,000
+42.9%
96,569
+45.4%
0.00%
Q2 2022$28,000
-67.4%
66,420
-2.7%
0.00%
Q1 2022$86,000
-1.1%
68,274
+1.7%
0.00%
Q4 2021$87,000
-40.0%
67,100
-5.0%
0.00%
Q3 2021$145,000
+20.8%
70,617
-7.4%
0.00%
Q2 2021$120,000
-17.8%
76,239
+15.9%
0.00%
Q1 2021$146,000
-42.3%
65,768
-35.4%
0.00%
Q4 2020$253,000
+39.0%
101,747
+37.2%
0.00%
Q3 2020$182,000
-34.3%
74,151
-5.2%
0.00%
Q2 2020$277,000
+64.9%
78,196
+9.1%
0.00%
Q1 2020$168,000
+8.4%
71,696
+1.9%
0.00%
Q4 2019$155,000
+23.0%
70,387
+2.3%
0.00%
Q3 2019$126,000
-21.2%
68,825
-37.8%
0.00%
Q2 2019$160,000
-3.0%
110,694
+32.5%
0.00%
Q1 2019$165,000
-14.5%
83,534
-43.2%
0.00%
Q4 2018$193,000
-47.7%
147,134
-2.0%
0.00%
Q3 2018$369,000
-29.6%
150,118
-3.8%
0.00%
Q2 2018$524,000
+5.6%
156,091
+33.1%
0.00%
Q1 2018$496,000
+34.1%
117,315
+4.4%
0.00%
Q4 2017$370,000
+11.1%
112,328
+28.7%
0.00%
Q3 2017$333,000
-67.4%
87,291
-62.4%
0.00%
Q2 2017$1,020,000
+254.2%
231,972
+194.4%
0.00%
Q1 2017$288,000
+500.0%
78,792
+355.6%
0.00%
Q4 2016$48,000
-48.4%
17,294
-38.8%
0.00%
Q3 2016$93,000
+322.7%
28,276
+334.1%
0.00%
Q2 2016$22,000
-12.0%
6,514
-35.1%
0.00%
Q1 2016$25,000
-97.6%
10,041
-96.8%
0.00%
Q4 2015$1,045,000318,7490.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q1 2022
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$89,0000.08%
Geier Asset Management, Inc. 35,000$91,0000.07%
Patriot Financial Group Insurance Agency, LLC 43,250$107,0000.03%
Willow Creek Wealth Management Inc. 24,224$60,0000.02%
WEBSTER BANK, N. A. 70,000$174,0000.02%
Brown Advisory Securities, LLC 28,000$69,0000.01%
Cubic Asset Management, LLC 11,250$28,0000.01%
Tower Research Capital LLC (TRC) 25,613$64,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$62,0000.00%
Sterling Investment Advisors, Ltd. 2,500$6,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders